Date:28-Apr-2024  Time: 2:07 AM
 
 
        
Aurobindo Pharma Ltd
Quarters:       (Rs. In Crores)
ParticularsDec 2023Sep 2023Jun 2023Mar 2023
Type3Qtr2Qtr1Qtr4Qtr
Net Sales2663.872648.412363.532371.73
Other Income331.13103.17112.83279.96
Total Income3023.162771.932503.652686.19
Total Expenditure 2210.342123.581968.441830.29
Operating Profit812.82648.35535.21855.90
Interest61.2536.6931.5931.77
Gross Profit751.57611.66503.62824.13
Depreciation64.3565.7959.6366.68
Tax136.95137.17116.30115.07
Deferred Tax-73.51-7.04-8.26-2.42
Reported Profit After Tax623.78415.74335.95644.80
Source:Capital Market
 
Useful linksNSEIBSEI SEBIINSDLI NCDEXI CDSLIRBI      Careers | Feedback | Sitemap | Disclaimer | Privacy Policy | Grievances
Sebi Reg No: NSE INB231168734(CM) INF231168734(F&O) Sebi Reg No: BSE INB011168730 INF011168730   NCDEX: Membership Code: 00774
MCX: Membership Code: 31560  Mutual Funds: ARN0843.
FMC Unique Membership Code: MCX/TCM/CORP/1106
2006-07 © Senator Securities Pvt. Ltd. All rights reserved
FMC Unique Membership Code: NCDEX/TCM/CORP/0760
Design, developed & maintained by C-MOTS Infotech(ISO 9001:2000 certified)
Content powered by capitalmarket.com